Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

David Badesch

Concepts (508)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension, Pulmonary
114
2025
1905
6.870
 Why?
Antihypertensive Agents
33
2025
487
3.050
 Why?
Epoprostenol
23
2015
136
1.890
 Why?
Vasodilator Agents
12
2015
331
1.160
 Why?
Recombinant Fusion Proteins
7
2025
664
1.120
 Why?
Registries
22
2025
2015
1.110
 Why?
Vascular Resistance
11
2025
372
1.070
 Why?
Familial Primary Pulmonary Hypertension
17
2024
198
1.010
 Why?
Pulmonary Wedge Pressure
9
2024
69
0.960
 Why?
Piperazines
8
2014
350
0.930
 Why?
Sulfones
7
2012
110
0.910
 Why?
Exercise Tolerance
21
2025
279
0.900
 Why?
Hemodynamics
30
2024
1110
0.890
 Why?
Scleroderma, Systemic
7
2021
122
0.760
 Why?
Connective Tissue Diseases
5
2018
84
0.740
 Why?
Practice Guidelines as Topic
7
2020
1571
0.730
 Why?
Sulfonamides
13
2018
513
0.720
 Why?
Double-Blind Method
25
2025
1981
0.660
 Why?
Exercise Test
11
2020
625
0.650
 Why?
Natriuretic Peptide, Brain
10
2025
99
0.650
 Why?
Phenylpropionates
5
2011
19
0.650
 Why?
Respiratory System Agents
2
2023
22
0.650
 Why?
Pulmonary Artery
14
2023
1086
0.610
 Why?
Pyridazines
5
2011
56
0.590
 Why?
Adult
78
2025
37631
0.580
 Why?
Cardiac Catheterization
13
2024
527
0.580
 Why?
Endothelin Receptor Antagonists
10
2015
62
0.570
 Why?
Humans
145
2025
136765
0.550
 Why?
Middle Aged
80
2025
33228
0.540
 Why?
Pyrimidines
4
2024
470
0.470
 Why?
Treatment Outcome
33
2025
10745
0.470
 Why?
Lung Transplantation
10
2025
313
0.440
 Why?
Disease Management
6
2016
624
0.430
 Why?
Male
92
2025
67311
0.430
 Why?
Female
89
2025
72795
0.420
 Why?
Aged
43
2025
23794
0.400
 Why?
Risk Assessment
14
2024
3432
0.390
 Why?
Thrombosis
1
2016
366
0.390
 Why?
Anticoagulants
3
2016
663
0.380
 Why?
Anemia, Sickle Cell
5
2014
269
0.380
 Why?
Pyrazoles
3
2024
423
0.360
 Why?
Consensus
1
2014
678
0.350
 Why?
Prognosis
16
2021
4013
0.350
 Why?
Thinness
1
2011
91
0.340
 Why?
Prostaglandins
3
2007
97
0.330
 Why?
Survival Rate
15
2022
1963
0.330
 Why?
Blood Pressure
8
2014
1774
0.310
 Why?
Oxygen Consumption
1
2012
695
0.300
 Why?
Hypertension, Portal
4
2011
64
0.300
 Why?
Activities of Daily Living
3
2016
413
0.300
 Why?
Sildenafil Citrate
8
2014
58
0.300
 Why?
Coagulants
1
2008
19
0.290
 Why?
Factor VIIa
1
2008
41
0.290
 Why?
Lung Neoplasms
1
2021
2489
0.280
 Why?
Quality of Life
12
2025
2878
0.270
 Why?
Purines
8
2014
176
0.270
 Why?
Surveys and Questionnaires
2
2018
5742
0.270
 Why?
Follow-Up Studies
17
2025
5106
0.270
 Why?
Depressive Disorder
1
2010
379
0.260
 Why?
Mixed Connective Tissue Disease
2
2010
10
0.260
 Why?
Hospitalization
8
2025
2182
0.260
 Why?
Evidence-Based Medicine
4
2019
738
0.260
 Why?
Health Status
2
2016
788
0.250
 Why?
Bone Morphogenetic Protein Receptors, Type II
2
2025
51
0.250
 Why?
Prospective Studies
16
2021
7572
0.240
 Why?
Pulmonary Medicine
3
2019
85
0.240
 Why?
Activins
1
2025
28
0.240
 Why?
Phosphodiesterase 5 Inhibitors
3
2014
37
0.230
 Why?
Hemorrhage
2
2008
721
0.230
 Why?
Pulmonary Disease, Chronic Obstructive
1
2012
1036
0.220
 Why?
Dose-Response Relationship, Drug
11
2021
2052
0.220
 Why?
Drug Therapy, Combination
7
2025
1062
0.220
 Why?
Castleman Disease
1
2003
13
0.210
 Why?
Referral and Consultation
2
2025
780
0.210
 Why?
Walk Test
4
2025
76
0.210
 Why?
United States
21
2025
14690
0.200
 Why?
Herpesvirus 8, Human
1
2003
65
0.200
 Why?
DEAE-Dextran
1
2023
1
0.200
 Why?
Muscle, Smooth, Vascular
6
1994
445
0.200
 Why?
Adolescent
22
2021
21382
0.190
 Why?
Phosphodiesterase Inhibitors
4
2009
89
0.190
 Why?
Ventricular Function, Right
5
2009
282
0.190
 Why?
Body Mass Index
1
2011
2375
0.190
 Why?
Herpesviridae Infections
1
2003
149
0.190
 Why?
Peptide Fragments
5
2025
705
0.190
 Why?
Biomarkers
6
2021
4144
0.180
 Why?
Insulin-Like Growth Factor I
4
1994
316
0.180
 Why?
Medication Adherence
1
2025
466
0.180
 Why?
Lung
7
2019
4062
0.180
 Why?
Fluid Shifts
1
2020
2
0.170
 Why?
Exercise Therapy
1
2025
436
0.170
 Why?
Adenocarcinoma, Mucinous
1
2021
80
0.170
 Why?
Severity of Illness Index
10
2024
2822
0.170
 Why?
Rituximab
1
2021
176
0.170
 Why?
Methamphetamine
1
2021
63
0.170
 Why?
Infusions, Intravenous
7
2009
412
0.170
 Why?
Heart
2
2023
653
0.170
 Why?
Vasculitis
2
1998
66
0.160
 Why?
Echocardiography
4
2020
642
0.160
 Why?
Somatomedins
2
1990
27
0.160
 Why?
Walking
8
2014
523
0.160
 Why?
Sodium Chloride
1
2020
142
0.160
 Why?
Disease Progression
5
2015
2750
0.160
 Why?
Thorax
1
2019
49
0.160
 Why?
Diagnostic Techniques, Respiratory System
1
2019
5
0.150
 Why?
Endothelin A Receptor Antagonists
2
2011
26
0.150
 Why?
Immunologic Factors
1
2021
236
0.150
 Why?
HLA-DP alpha-Chains
1
2018
4
0.150
 Why?
Isoxazoles
3
2008
54
0.150
 Why?
SOXF Transcription Factors
1
2018
16
0.150
 Why?
Thiophenes
3
2008
117
0.150
 Why?
HLA-DP beta-Chains
1
2018
86
0.150
 Why?
Transforming Growth Factor beta
1
2021
480
0.140
 Why?
Administration, Oral
9
2015
813
0.140
 Why?
Young Adult
10
2021
13127
0.140
 Why?
Time Factors
14
2018
6808
0.140
 Why?
Algorithms
5
2019
1689
0.140
 Why?
Liver Diseases
3
2011
311
0.140
 Why?
Blood Coagulation
2
2016
255
0.140
 Why?
Obesity
1
2011
2982
0.140
 Why?
Drug Monitoring
1
2019
218
0.140
 Why?
Psychometrics
2
2018
720
0.130
 Why?
Proportional Hazards Models
6
2022
1261
0.130
 Why?
Comorbidity
5
2019
1614
0.130
 Why?
Oxygen Inhalation Therapy
1
2018
157
0.130
 Why?
Randomized Controlled Trials as Topic
5
2024
1462
0.130
 Why?
Pyridines
2
2015
506
0.120
 Why?
Diagnostic Imaging
1
2019
328
0.120
 Why?
B-Lymphocytes
1
2021
846
0.120
 Why?
Iloprost
2
2006
45
0.120
 Why?
Kaplan-Meier Estimate
4
2025
888
0.120
 Why?
Calcium Channel Blockers
2
2024
167
0.120
 Why?
Tetrazoles
1
2015
40
0.120
 Why?
Pulmonary Edema
1
1995
107
0.120
 Why?
Cohort Studies
7
2020
5701
0.110
 Why?
Hemolysis
2
2014
206
0.110
 Why?
Survival Analysis
8
2018
1321
0.110
 Why?
Graft Rejection
1
1998
620
0.110
 Why?
Pilot Projects
4
2010
1692
0.110
 Why?
Case-Control Studies
5
2018
3539
0.100
 Why?
Models, Theoretical
2
2015
575
0.100
 Why?
Antibodies, Antinuclear
1
1993
71
0.100
 Why?
Acute Disease
3
2008
1006
0.100
 Why?
Pancreatic Neoplasms
1
2021
935
0.100
 Why?
Societies, Medical
2
2015
816
0.100
 Why?
Protein Kinase C
2
1994
261
0.100
 Why?
Exercise
4
2024
2043
0.100
 Why?
Echocardiography, Doppler
2
2014
108
0.100
 Why?
Colorado
3
2022
4515
0.100
 Why?
Hypothyroidism
1
1993
72
0.100
 Why?
Delphi Technique
1
2014
273
0.100
 Why?
Respiratory Function Tests
5
2018
595
0.100
 Why?
Patient Reported Outcome Measures
1
2016
402
0.100
 Why?
Endpoint Determination
2
2010
77
0.100
 Why?
Incidence
5
2015
2792
0.100
 Why?
Injections, Subcutaneous
2
2023
154
0.090
 Why?
Pulmonary Circulation
3
2018
429
0.090
 Why?
Extracorporeal Membrane Oxygenation
1
1995
291
0.090
 Why?
Survival
1
2011
38
0.090
 Why?
Risk Factors
9
2018
10325
0.090
 Why?
Diagnosis, Differential
3
2020
1481
0.090
 Why?
Peptidyl-Dipeptidase A
3
2003
52
0.090
 Why?
Pain
2
2011
754
0.090
 Why?
United Kingdom
3
2021
310
0.090
 Why?
Prevalence
4
2010
2710
0.090
 Why?
Respiration, Artificial
1
1995
642
0.090
 Why?
Long-Term Care
1
2011
106
0.080
 Why?
Michigan
1
2010
108
0.080
 Why?
Retrospective Studies
8
2025
15504
0.080
 Why?
Reference Values
2
2009
816
0.080
 Why?
Animals, Newborn
5
1994
844
0.080
 Why?
Guideline Adherence
2
2018
546
0.080
 Why?
Endothelin-1
2
2002
182
0.080
 Why?
Pulmonary Alveoli
2
2005
405
0.080
 Why?
Aldosterone
1
2009
45
0.080
 Why?
Dinoprostone
1
1989
191
0.080
 Why?
Elastin
1
1989
78
0.080
 Why?
Pulmonary Eosinophilia
1
1989
27
0.080
 Why?
Vasopressins
1
2009
64
0.080
 Why?
Transaminases
1
2008
24
0.070
 Why?
Serotonin Plasma Membrane Transport Proteins
1
2009
75
0.070
 Why?
Aged, 80 and over
8
2021
7585
0.070
 Why?
Vasoconstrictor Agents
1
2009
139
0.070
 Why?
Renal Insufficiency
1
2010
155
0.070
 Why?
Ventricular Dysfunction, Left
1
2011
382
0.070
 Why?
Maximum Tolerated Dose
2
2025
199
0.070
 Why?
Alveolitis, Extrinsic Allergic
1
1989
97
0.070
 Why?
Lung Diseases
2
2010
768
0.070
 Why?
Hospitals, University
1
2008
182
0.070
 Why?
Multivariate Analysis
4
2015
1507
0.070
 Why?
Platelet Aggregation Inhibitors
3
2004
462
0.070
 Why?
Heart Failure
2
2020
2231
0.070
 Why?
Ventricular Dysfunction, Right
3
2009
235
0.070
 Why?
Genetic Predisposition to Disease
3
2018
2412
0.070
 Why?
Lupus Erythematosus, Systemic
3
2010
242
0.070
 Why?
Drug Utilization
1
2008
169
0.070
 Why?
Airway Obstruction
1
2009
162
0.070
 Why?
Drug Costs
1
2008
106
0.070
 Why?
Endothelins
1
2007
65
0.070
 Why?
Hypophosphatemia
1
2006
17
0.070
 Why?
Educational Measurement
1
1989
280
0.070
 Why?
Hypokalemia
1
2006
24
0.070
 Why?
Clinical Trials as Topic
2
2009
1044
0.070
 Why?
Appetite Depressants
1
2006
18
0.060
 Why?
Autoimmune Diseases
2
2005
460
0.060
 Why?
Depressive Disorder, Major
1
2010
362
0.060
 Why?
Phosphorus
1
2006
97
0.060
 Why?
Potassium
1
2006
147
0.060
 Why?
Ventricular Function
1
2006
61
0.060
 Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2005
17
0.060
 Why?
Medical Informatics
1
2006
101
0.060
 Why?
Cattle
5
1994
981
0.060
 Why?
CREST Syndrome
2
2002
7
0.060
 Why?
Pleural Diseases
1
2005
23
0.060
 Why?
Probability
3
2015
304
0.060
 Why?
Analysis of Variance
3
2009
1316
0.060
 Why?
Forecasting
3
2021
386
0.060
 Why?
Child
6
2011
21819
0.060
 Why?
Predictive Value of Tests
3
2016
2022
0.060
 Why?
Recombinant Proteins
1
2008
1350
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2024
105
0.060
 Why?
Immunohistochemistry
3
2005
1733
0.060
 Why?
Arthritis, Rheumatoid
3
2010
1167
0.060
 Why?
Carbon Monoxide
2
2018
80
0.060
 Why?
Heterozygote
1
2025
293
0.060
 Why?
Terminology as Topic
1
2005
216
0.050
 Why?
Age Distribution
3
2010
389
0.050
 Why?
Physicians, Family
1
2005
201
0.050
 Why?
Sex Distribution
3
2010
373
0.050
 Why?
Physician's Role
1
2005
211
0.050
 Why?
Heart Defects, Congenital
2
2009
833
0.050
 Why?
Neoplasm Metastasis
1
2005
657
0.050
 Why?
Polymyositis
1
2002
15
0.050
 Why?
Scleroderma, Localized
1
2002
10
0.050
 Why?
Statistics, Nonparametric
2
2003
431
0.050
 Why?
Serotonin Antagonists
1
2002
32
0.050
 Why?
Dermatomyositis
1
2002
27
0.050
 Why?
Hypoxia
3
2018
1112
0.050
 Why?
Thromboxane-A Synthase
1
2002
3
0.050
 Why?
Cardiac Surgical Procedures
1
2008
530
0.050
 Why?
Liver Function Tests
3
2011
114
0.050
 Why?
Enzyme Inhibitors
2
2004
839
0.050
 Why?
Polymerase Chain Reaction
2
2003
1059
0.050
 Why?
Clinical Competence
1
1989
1093
0.050
 Why?
Animals
11
2013
36847
0.050
 Why?
Signal Transduction
4
2025
5076
0.050
 Why?
Drug Administration Schedule
4
2008
785
0.050
 Why?
Mutation
2
2025
3946
0.050
 Why?
Biomarkers, Pharmacological
1
2021
28
0.050
 Why?
Cholangiopancreatography, Magnetic Resonance
1
2021
24
0.050
 Why?
Tricuspid Valve Insufficiency
2
2011
24
0.040
 Why?
Cardiovascular Agents
1
2023
159
0.040
 Why?
Multicenter Studies as Topic
2
2006
308
0.040
 Why?
Adjuvants, Immunologic
1
2002
226
0.040
 Why?
Least-Squares Analysis
1
2021
79
0.040
 Why?
Injections, Intravenous
2
2013
207
0.040
 Why?
Polymorphism, Single Nucleotide
3
2018
2184
0.040
 Why?
Tropoelastin
2
1991
11
0.040
 Why?
Lymph Nodes
1
2003
492
0.040
 Why?
Self Report
1
2025
822
0.040
 Why?
Reproductive History
1
2020
17
0.040
 Why?
Risk
2
2015
908
0.040
 Why?
Cells, Cultured
5
1994
4191
0.040
 Why?
Europe
2
2012
413
0.040
 Why?
Infusion Pumps
1
2000
32
0.040
 Why?
Jaw
1
2000
26
0.040
 Why?
Cardiac Output
1
2020
164
0.040
 Why?
Radiography
2
1995
822
0.040
 Why?
Autoimmunity
1
2005
908
0.040
 Why?
Genotype
4
2009
1914
0.040
 Why?
Transplantation, Homologous
2
1998
415
0.040
 Why?
Reproducibility of Results
2
2019
3265
0.040
 Why?
Placebos
2
2011
199
0.040
 Why?
Delivery of Health Care
1
2006
934
0.040
 Why?
Symptom Assessment
1
2020
128
0.040
 Why?
Internship and Residency
1
1989
1132
0.040
 Why?
Spinal Diseases
1
1999
48
0.040
 Why?
Intramolecular Oxidoreductases
1
1999
68
0.040
 Why?
Gonadal Steroid Hormones
1
2020
140
0.040
 Why?
Thrombocytopenia
1
2021
198
0.040
 Why?
Lung Diseases, Interstitial
1
2005
636
0.040
 Why?
Genotyping Techniques
1
2018
75
0.040
 Why?
Uric Acid
1
2000
163
0.040
 Why?
Cytochrome P-450 Enzyme System
1
1999
155
0.040
 Why?
Methicillin Resistance
1
1998
18
0.040
 Why?
Plasmapheresis
1
1998
24
0.040
 Why?
Cervical Vertebrae
1
1999
135
0.040
 Why?
Pulmonary Diffusing Capacity
1
2018
75
0.040
 Why?
Immunosuppressive Agents
3
1998
889
0.040
 Why?
Hemoptysis
1
1998
36
0.040
 Why?
Cell Division
4
1994
796
0.040
 Why?
Models, Statistical
1
2022
667
0.040
 Why?
Bronchiolitis Obliterans
1
1998
69
0.040
 Why?
Gastrointestinal Diseases
1
2000
209
0.030
 Why?
Disease-Free Survival
2
2010
685
0.030
 Why?
Child, Preschool
2
2011
10997
0.030
 Why?
alpha 1-Antitrypsin Deficiency
1
1998
67
0.030
 Why?
Capillaries
1
1998
108
0.030
 Why?
Biomedical Technology
1
2017
43
0.030
 Why?
Fatal Outcome
1
1998
303
0.030
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1997
42
0.030
 Why?
Health Status Indicators
2
2009
168
0.030
 Why?
Faculty, Medical
2
1990
283
0.030
 Why?
Colonic Diseases
1
1996
33
0.030
 Why?
Myosin Heavy Chains
1
1997
191
0.030
 Why?
Blood Coagulation Factors
1
1996
54
0.030
 Why?
Mycoplasma
1
1996
5
0.030
 Why?
Intestinal Perforation
1
1996
46
0.030
 Why?
Mycoplasma Infections
1
1996
15
0.030
 Why?
Mass Screening
2
2018
1267
0.030
 Why?
Desensitization, Immunologic
1
1997
95
0.030
 Why?
Translating
1
2016
43
0.030
 Why?
Drug Hypersensitivity
1
1997
90
0.030
 Why?
Myocardium
2
1998
1001
0.030
 Why?
Cardiomyopathy, Dilated
1
1999
383
0.030
 Why?
Comparative Effectiveness Research
1
2016
150
0.030
 Why?
Endothelium, Vascular
2
1994
926
0.030
 Why?
Dyspnea
2
2008
254
0.030
 Why?
Pulmonary Emphysema
1
1998
288
0.030
 Why?
Fibrinolysis
1
1996
143
0.030
 Why?
Lactobacillus
1
1994
29
0.030
 Why?
Calibration
1
2015
146
0.030
 Why?
Recurrence
1
1998
1055
0.030
 Why?
Longitudinal Studies
2
2014
2829
0.030
 Why?
South Africa
1
2015
219
0.030
 Why?
Tetradecanoylphorbol Acetate
2
1994
150
0.030
 Why?
Immunization, Passive
1
1994
90
0.030
 Why?
Drug Approval
1
2015
87
0.030
 Why?
Antisickling Agents
1
2014
8
0.030
 Why?
Ferritins
1
2014
64
0.030
 Why?
Hydroxyurea
1
2014
35
0.030
 Why?
Immunoglobulins
1
1994
171
0.030
 Why?
Cross-Sectional Studies
3
2016
5423
0.030
 Why?
United States Food and Drug Administration
1
2015
208
0.030
 Why?
Gram-Positive Bacterial Infections
1
1994
70
0.030
 Why?
Social Behavior
1
2016
284
0.030
 Why?
Thyroiditis
1
1993
4
0.030
 Why?
Raynaud Disease
1
1993
5
0.030
 Why?
Emergency Service, Hospital
1
2025
2046
0.030
 Why?
Cytomegalovirus
1
1994
157
0.030
 Why?
Research
2
2009
448
0.030
 Why?
Genetic Variation
1
2018
985
0.030
 Why?
Focus Groups
1
2016
515
0.030
 Why?
Pneumonia, Bacterial
1
1994
116
0.030
 Why?
Administration, Intravenous
1
2014
155
0.030
 Why?
Staphylococcal Infections
1
1998
399
0.030
 Why?
Immunoenzyme Techniques
2
1994
219
0.030
 Why?
Down Syndrome
1
1999
490
0.020
 Why?
Erythrocyte Indices
1
2012
30
0.020
 Why?
Cytomegalovirus Infections
1
1994
192
0.020
 Why?
Enzyme Activation
2
1994
810
0.020
 Why?
Blood Flow Velocity
1
2014
412
0.020
 Why?
Pulmonary Embolism
1
2015
225
0.020
 Why?
Creatinine
1
2014
499
0.020
 Why?
Embolism, Air
1
1992
14
0.020
 Why?
Erythrocyte Transfusion
1
2014
193
0.020
 Why?
Genome-Wide Association Study
1
2018
1428
0.020
 Why?
Preoperative Care
2
2009
356
0.020
 Why?
Cell-Derived Microparticles
1
2012
71
0.020
 Why?
Chronic Disease
2
2015
1785
0.020
 Why?
Biomedical Research
1
2017
688
0.020
 Why?
Cardiomegaly
2
2006
175
0.020
 Why?
Homozygote
1
2011
203
0.020
 Why?
Emotions
1
2016
545
0.020
 Why?
Thromboxane B2
1
1989
26
0.020
 Why?
Calcimycin
1
1989
49
0.020
 Why?
Mortality
1
2012
359
0.020
 Why?
Decision Support Techniques
1
2014
418
0.020
 Why?
Mental Health
1
2016
716
0.020
 Why?
Cost-Benefit Analysis
1
2012
587
0.020
 Why?
Phenotype
3
2010
3189
0.020
 Why?
Drug Synergism
1
1990
382
0.020
 Why?
Fellowships and Scholarships
2
1990
303
0.020
 Why?
Health Care Costs
1
2012
384
0.020
 Why?
Angiopoietin-1
1
2009
11
0.020
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2009
22
0.020
 Why?
Nitric Oxide
1
1994
915
0.020
 Why?
Health Policy
1
2012
385
0.020
 Why?
Receptors, Retinoic Acid
1
2009
43
0.020
 Why?
Qualitative Research
1
2016
1366
0.020
 Why?
Aromatase
1
2009
32
0.020
 Why?
Spironolactone
1
2009
36
0.020
 Why?
Dyspepsia
1
2008
10
0.020
 Why?
Nucleic Acid Hybridization
1
1989
190
0.020
 Why?
California
1
2010
428
0.020
 Why?
Mineralocorticoid Receptor Antagonists
1
2009
54
0.020
 Why?
Pulmonary Veins
1
1989
99
0.020
 Why?
Hepatitis, Autoimmune
1
2008
20
0.020
 Why?
In Vitro Techniques
1
1990
1089
0.020
 Why?
Cognition
1
2016
1146
0.020
 Why?
Echocardiography, Transesophageal
1
2009
96
0.020
 Why?
Confidence Intervals
1
2009
328
0.020
 Why?
Vital Capacity
1
2009
311
0.020
 Why?
Cystic Fibrosis
1
1998
1108
0.020
 Why?
Vibrio Infections
1
1987
2
0.020
 Why?
Down-Regulation
1
1990
656
0.020
 Why?
Headache
1
2008
147
0.020
 Why?
Calcium-Binding Proteins
1
2009
218
0.020
 Why?
Estrogen Receptor alpha
1
2009
145
0.020
 Why?
Forced Expiratory Volume
1
2009
531
0.020
 Why?
American Heart Association
1
2009
306
0.020
 Why?
Endocarditis, Bacterial
1
1987
41
0.020
 Why?
Aminorex
1
2006
2
0.020
 Why?
Protein Biosynthesis
1
1989
430
0.020
 Why?
RNA, Messenger
2
1997
2831
0.020
 Why?
Heart Rate
1
2010
820
0.020
 Why?
Odds Ratio
1
2009
1065
0.020
 Why?
Hypoventilation
1
1985
11
0.020
 Why?
Alleles
1
2009
890
0.020
 Why?
Magnetic Resonance Imaging
3
2006
3555
0.020
 Why?
Estradiol
1
2009
518
0.010
 Why?
Biopsy, Needle
1
2005
189
0.010
 Why?
Hepatitis C
1
2008
267
0.010
 Why?
Statistics as Topic
1
2006
307
0.010
 Why?
Magnesium
1
1985
156
0.010
 Why?
Gene Expression Regulation
2
1997
2605
0.010
 Why?
Drug Prescriptions
1
2006
243
0.010
 Why?
Fibroblasts
1
1989
993
0.010
 Why?
Pancreatic Elastase
1
2004
58
0.010
 Why?
Critical Care
1
1989
583
0.010
 Why?
Hypotension
1
1985
122
0.010
 Why?
Aging
1
1994
1864
0.010
 Why?
Sensitivity and Specificity
1
2009
1935
0.010
 Why?
Logistic Models
1
2009
2067
0.010
 Why?
Tablets
1
2003
40
0.010
 Why?
Potassium Channels
1
2004
151
0.010
 Why?
DNA
1
1990
1458
0.010
 Why?
Research Design
1
2009
1127
0.010
 Why?
Arginine
1
2004
271
0.010
 Why?
Angiotensin II
1
2003
99
0.010
 Why?
Sex Factors
1
2008
2060
0.010
 Why?
Attitude of Health Personnel
1
2010
1163
0.010
 Why?
Rats
2
2004
5639
0.010
 Why?
Sepsis
1
1987
614
0.010
 Why?
Liver Transplantation
1
2009
871
0.010
 Why?
Heart Ventricles
1
2006
785
0.010
 Why?
Practice Patterns, Physicians'
1
2010
1301
0.010
 Why?
Colorimetry
1
2000
12
0.010
 Why?
Spinal Osteophytosis
1
1999
3
0.010
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2004
443
0.010
 Why?
Ovarian Neoplasms
1
2005
562
0.010
 Why?
Spinal Cord Compression
1
1999
20
0.010
 Why?
Spinal Stenosis
1
1999
30
0.010
 Why?
Veins
1
1999
62
0.010
 Why?
Heart Atria
1
2000
137
0.010
 Why?
In Situ Hybridization
1
1999
316
0.010
 Why?
Calcium-Transporting ATPases
1
1997
40
0.010
 Why?
Atrial Natriuretic Factor
1
1997
57
0.010
 Why?
Heart-Lung Transplantation
1
1997
14
0.010
 Why?
Arteries
1
1999
269
0.010
 Why?
Tissue Distribution
1
1997
330
0.010
 Why?
Receptors, Adrenergic, beta
1
1997
127
0.010
 Why?
Diverticulitis, Colonic
1
1996
7
0.010
 Why?
Spinal Cord
1
1999
370
0.010
 Why?
Models, Biological
1
2004
1773
0.010
 Why?
Liver Cirrhosis
1
1999
316
0.010
 Why?
Systole
1
1997
189
0.010
 Why?
Blotting, Western
1
1999
1225
0.010
 Why?
von Willebrand Factor
1
1996
80
0.010
 Why?
Respiration
1
1996
199
0.010
 Why?
Proteins
2
1992
1008
0.010
 Why?
Physical Fitness
1
1997
208
0.010
 Why?
Ventricular Function, Left
1
1999
533
0.010
 Why?
Cilazapril
1
1995
2
0.010
 Why?
Electrophoresis, Agar Gel
1
1995
26
0.010
 Why?
Thymidine
1
1994
60
0.010
 Why?
Ganciclovir
1
1994
53
0.010
 Why?
Subcellular Fractions
1
1994
82
0.010
 Why?
Image Processing, Computer-Assisted
1
1999
752
0.010
 Why?
Opportunistic Infections
1
1994
45
0.010
 Why?
Lung Diseases, Obstructive
1
1994
50
0.010
 Why?
Acyclovir
1
1994
101
0.010
 Why?
Blood
1
1994
107
0.010
 Why?
Tissue Donors
1
1997
417
0.010
 Why?
Immunoglobulins, Intravenous
1
1994
132
0.010
 Why?
Vimentin
1
1994
52
0.010
 Why?
Viremia
1
1994
138
0.010
 Why?
Factor VIII
1
1994
98
0.010
 Why?
Liver
1
2002
1940
0.010
 Why?
Gene Expression
1
1998
1500
0.010
 Why?
Immunocompromised Host
1
1994
202
0.010
 Why?
Administration, Inhalation
1
1994
683
0.010
 Why?
Sputum
1
1994
311
0.010
 Why?
Neovascularization, Pathologic
1
1994
301
0.010
 Why?
Lymph
1
1992
32
0.010
 Why?
Blotting, Northern
1
1991
200
0.010
 Why?
Flow Cytometry
1
1994
1180
0.010
 Why?
Antibodies, Viral
1
1994
624
0.010
 Why?
Extracellular Matrix Proteins
1
1991
153
0.010
 Why?
Financing, Government
1
1990
47
0.010
 Why?
Career Mobility
1
1990
68
0.010
 Why?
National Institutes of Health (U.S.)
1
1990
128
0.000
 Why?
Pneumonia, Viral
1
1994
368
0.000
 Why?
Research Support as Topic
1
1990
119
0.000
 Why?
Tomography, X-Ray Computed
1
1999
2667
0.000
 Why?
Rats, Sprague-Dawley
1
1995
2486
0.000
 Why?
Sheep
1
1992
856
0.000
 Why?
Vibrio
1
1987
3
0.000
 Why?
Hepatitis, Alcoholic
1
1987
13
0.000
 Why?
Citrates
1
1985
44
0.000
 Why?
Protein Binding
1
1992
2216
0.000
 Why?
Kidney Function Tests
1
1985
159
0.000
 Why?
Postoperative Complications
1
1997
2639
0.000
 Why?
RNA
1
1991
921
0.000
 Why?
HIV Infections
1
1999
2828
0.000
 Why?
Disease Models, Animal
1
1995
4282
0.000
 Why?
Anti-Bacterial Agents
1
1994
1797
0.000
 Why?
Infant
1
1994
9395
0.000
 Why?
Badesch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (508) concept(s)
_
Co-Authors Expand Description
See all (35) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)